A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature
-
Published:2024-02-22
Issue:3
Volume:14
Page:235
-
ISSN:2075-4426
-
Container-title:Journal of Personalized Medicine
-
language:en
-
Short-container-title:JPM
Author:
Mercuț Maria Filoftea1, Ică Oana Maria2, Tănasie Cornelia Andreea3, Mercuț Răzvan4, Mocanu Carmen Luminița1, Nicolcescu Andreea Mihaela5, Danielescu Ciprian6
Affiliation:
1. Department of Ophthalmology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania 2. Department of Dermatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania 3. Department of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania 4. Department of Plastic Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania 5. Department of Ophthalmology, Clinical County Emergency Hospital, 200642 Craiova, Romania 6. Department of Ophthalmology, University of Medicine and Pharmacy Grigorie T. Popa Iasi, 700115 Iasi, Romania
Abstract
Eales disease manifests as an obliterative periphlebitis affecting the retina; it originates from the periphery and progresses posteriorly. It is characterized by retinal vessel wall inflammation, ischemia, and retinal neovascularization. In this report, we present the case of a 34-year-old male who attended our clinic with a sudden blurring of vision in his right eye. A diagnosis of bilateral retinal vasculitis with vitreal hemorrhage was ascertained in his RE. A dilated ocular fundus examination revealed perivenous sheathing of the peripheral vessels in both eyes. Fluorescein angiography indicated dye staining, vessel obliteration, capillary drop-out, areas of non-perfusion and the formation of new vessels. Laboratory tests revealed positive results for Borrelia; a PPD skin test and QuantiFERON TB assay were also positive. The patient underwent bilateral retinal laser pan-photocoagulation, followed by systemic treatment with oral steroids, cephazoline, isoniazid, azathioprine, and entecavir. The steroid dose was progressively reduced over 10 months; the treatment with azathioprine continues, as we are monitoring the patient over the long term. After 3 months, the vasculitis had regressed without any vitreal hemorrhage recurrence. Vision acuity improved from 0.4 to 1 in the patient’s right eye. A multidisciplinary approach, which included collaborative management with gastroenterology, infectious disease, pulmonology, and rheumatology specialists, was essential for the diagnosis, treatment, and long-term follow up of the patient.
Reference33 articles.
1. Raizada, K., and Tripathy, K. (2023). StatPearls Internet, StatPearls Publishing. 2. Nebbioso, M., Franzone, F., Lambiase, A., Bonfiglio, V., Limoli, P., Artico, M., Taurone, S., Vingolo, E., Greco, A., and Polimeni, A. (2022). Oxidative Stress Implication in Retinal Diseases—A Review. Antioxidants, 11. 3. Murugeswari, P., Kim, S.D.R., Stitt, N.P.A., and Muthukkaruppan, V. (2014). Angiogenic potential of vitreous from Proliferative Diabetic Retinopathy and Eales’ Disease patients. PLoS ONE, 9. 4. Rossino, M., Lulli, M., Amato, R., Cammalleri, M., Monte, M., and Casini, G. (2020). Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy. Cells, 9. 5. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales’ disease;Madhavan;Investig. Ophthalmol. Vis. Sci.,2000
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|